[The enterochromaffin system and clinical consequences of hyperserotonism].
D001706:Biopsy; D002838:Chromaffin System; D003490:Cyanosis / Q000150:complications; D003864:Depression, Chemical; D005260:Female; D006333:Heart Failure / Q000150:complications; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000652:urine*; D007413:Intestinal Mucosa / Q000473:pathology; D007421:Intestine, Small / Q000473:pathology; D008113:Liver Neoplasms / Q000097:blood / Q000473:pathology* / Q000652:urine; D008297:Male; D008303:Malignant Carcinoid Syndrome / Q000097:blood* / Q000473:pathology / Q000652:urine*; D008784:Methysergide / Q000627:therapeutic use*; D008854:Microscopy, Electron; D009362:Neoplasm Metastasis / Q000473:pathology; D011666:Pulmonary Valve Stenosis / Q000150:complications; D012701:Serotonin / Q000097:blood*; D012702:Serotonin Antagonists
D012702:Serotonin Antagonists; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D008784:Methysergide
Das enterochromaffine System und klinische Konsequenzen des Hyperserotonismus.